1.Development of a Training Program on the Proper Use of Over-the-Counter Drugs for Pharmacy Pharmacists
Chie HIRAOKA ; Keiko (Sasaki) AKAGAWA ; Yoshiaki FUJITA ; Yuki ODANAKA ; Atsuhiko SANO ; Mika NAGANUMA ; Tetsuya OGINO ; Hajime KATO ; Akihiro NAKAMURA
Japanese Journal of Social Pharmacy 2022;41(2):155-166
The importance of promoting self-medication is increasing, and the active participation of pharmacies is required to support this. We developed a training program based on the Attention, Relevance, Confidence, and Satisfaction (ARCS) model, which is a motivational design process to train pharmacists who support the proper use of OTC drugs, and for insurance pharmacists who usually perform dispensing work. In the six months of training, we conducted six sessions for insurance pharmacists on the subject of colds and constipation. In addition to conducting lectures and exercises on OTC drugs, we provided pharmacists with an opportunity to practice the training content during their daily work, and discuss solutions to the problems that they encountered. Of the eight participants who attended all workshops and were part of the final evaluation, seven provided OTC drugs after considering whether it was necessary to provide them. A total of six advised patients who came to the pharmacy to have their prescription medications dispensed that there were OTC medications that they should be careful about taking. These results suggest the usefulness of this training program based on the ARCS motivational design model.
2.End of Life Discussions in Heart Failure Patients
Kosaku OUE ; Yuka IMAMURA ; Reika YAGI ; Naomi INOUE ; Keiko KADO ; Takao KATO ; Yuki SHIRAI
Palliative Care Research 2022;17(3):119-126
Purpose: This study aimed to investigate the current status and related factors of End of Life discussions between heart failure patients and medical professionals. Method: We conducted a survey of medical records of patients who died between April 2015 and March 2020 in the Department of Cardiology, Kyoto University Hospital. We examined the presence or absence of discussions about prognosis and end-of-life care and their associated factors. Result: Of the 109 patients, prognosis was explained to 40 (36.7%) and discussion of end-of-life care was provided to 25 (22.9%). Age (younger), number of hospitalizations, palliative care team intervention, and end-of-life care discussions were associated with the prognostic explanations. Gender (male), number of hospitalizations, history of heart failure hospitalization, palliative care team intervention, and prognosis explanation were associated with the end-of-life care discussions. Conclusion: The study suggested that End of Life discussions in heart failure patients are currently focused on patients with severe and end-stage heart failure.
3.Clinical Characteristics of Esophageal Motility Disorders in Patients With Heartburn
Satsuki TAKAHASHI ; Tomoaki MATSUMURA ; Tatsuya KANEKO ; Mamoru TOKUNAGA ; Hirotaka OURA ; Tsubasa ISHIKAWA ; Ariki NAGASHIMA ; Wataru SHIRATORI ; Naoki AKIZUE ; Yuki OHTA ; Atsuko KIKUCHI ; Mai FUJIE ; Keiko SAITO ; Kenichiro OKIMOTO ; Daisuke MARUOKA ; Tomoo NAKAGAWA ; Makoto ARAI ; Jun KATO ; Naoya KATO
Journal of Neurogastroenterology and Motility 2021;27(4):545-554
Background/Aims:
Esophageal motility disorders (EMDs) contribute to the pathophysiology of gastroesophageal reflux disease. However, the causes of EMDs and their impact on gastroesophageal reflux disease-associated symptoms remain unknown. This study aims to elucidate clinical features associated with various types of EMDs in patients with heartburn symptoms.
Methods:
Of the 511 patients who underwent high-resolution manometry, 394 who were evaluated for heartburn symptoms were examined. Patients subjected to high-resolution manometry were classified into 4 groups: outflow obstruction group, hypermotility group, hypomotility group, and normal motility group. Symptoms were evaluated using 3 questionnaires. Patient characteristics and symptoms for each EMD type were compared with those of the normal motility group.
Results:
Of the 394 patients, 193 (48.9%) were diagnosed with EMDs, including 71 with outflow obstruction, 15 with hypermotility, and 107 with hypomotility. The mean dysphagia score was significantly higher in each of the 3 EMD groups compared with those with normal motility. The mean acid reflux and dyspepsia scores were significantly lower in the outflow obstruction group (P < 0.05). The mean body mass index and median Brinkman index were significantly higher in the hypermotility group (P = 0.001 and P = 0.018, respectively), whereas the mean diarrhea and constipation scores were significantly lower in the hypomotility group (P < 0.05).
Conclusions
The results of our study indicate that different EMDs have distinct characteristics. Cigarette smoking and high body mass index were associated with esophageal hypermotility. Assessment of the dysphagia symptom scores may help identify patients with EMDs.
4.Clinical Characteristics of Esophageal Motility Disorders in Patients With Heartburn
Satsuki TAKAHASHI ; Tomoaki MATSUMURA ; Tatsuya KANEKO ; Mamoru TOKUNAGA ; Hirotaka OURA ; Tsubasa ISHIKAWA ; Ariki NAGASHIMA ; Wataru SHIRATORI ; Naoki AKIZUE ; Yuki OHTA ; Atsuko KIKUCHI ; Mai FUJIE ; Keiko SAITO ; Kenichiro OKIMOTO ; Daisuke MARUOKA ; Tomoo NAKAGAWA ; Makoto ARAI ; Jun KATO ; Naoya KATO
Journal of Neurogastroenterology and Motility 2021;27(4):545-554
Background/Aims:
Esophageal motility disorders (EMDs) contribute to the pathophysiology of gastroesophageal reflux disease. However, the causes of EMDs and their impact on gastroesophageal reflux disease-associated symptoms remain unknown. This study aims to elucidate clinical features associated with various types of EMDs in patients with heartburn symptoms.
Methods:
Of the 511 patients who underwent high-resolution manometry, 394 who were evaluated for heartburn symptoms were examined. Patients subjected to high-resolution manometry were classified into 4 groups: outflow obstruction group, hypermotility group, hypomotility group, and normal motility group. Symptoms were evaluated using 3 questionnaires. Patient characteristics and symptoms for each EMD type were compared with those of the normal motility group.
Results:
Of the 394 patients, 193 (48.9%) were diagnosed with EMDs, including 71 with outflow obstruction, 15 with hypermotility, and 107 with hypomotility. The mean dysphagia score was significantly higher in each of the 3 EMD groups compared with those with normal motility. The mean acid reflux and dyspepsia scores were significantly lower in the outflow obstruction group (P < 0.05). The mean body mass index and median Brinkman index were significantly higher in the hypermotility group (P = 0.001 and P = 0.018, respectively), whereas the mean diarrhea and constipation scores were significantly lower in the hypomotility group (P < 0.05).
Conclusions
The results of our study indicate that different EMDs have distinct characteristics. Cigarette smoking and high body mass index were associated with esophageal hypermotility. Assessment of the dysphagia symptom scores may help identify patients with EMDs.
5.Multiple Basal Cell Carcinomas with Infundibular Structures and Trichoblastoma
Kohei KATO ; Takeshi NAMIKI ; Rana KAWAI ; Keiko MIURA ; Hiroo YOKOZEKI ; Kazumoto KATAGIRI
Annals of Dermatology 2019;31(2):259-261
No abstract available.
Carcinoma, Basal Cell
6.Fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient with ulcerative colitis
Kosaku NANKI ; Shinta MIZUNO ; Katsuyoshi MATSUOKA ; Keiko ONO ; Shinya SUGIMOTO ; Hiroki KIYOHARA ; Mari ARAI ; Moeko NAKASHIMA ; Kozue TAKESHITA ; Keiichiro SAIGUSA ; Mitsutoshi SENOH ; Tadashi FUKUDA ; Makoto NAGANUMA ; Haru KATO ; Wataru SUDA ; Masahira HATTORI ; Takanori KANAI
Intestinal Research 2018;16(1):142-146
Fecal microbiota transplantation (FMT) has been reported as a safe and effective therapy in patients with refractory and recurrent Clostridium difficile infection (CDI). FMT has also been reported as a promising therapy in patients with ulcerative colitis (UC). Both, CDI and UC, are believed to be caused by dysbiosis, such as altered compositions or decreased diversity of the intestinal microbiota. This report describes a patient with UC in remission with a second recurrent episode of CDI, who was treated with FMT. A single FMT performed via colonoscopy completely resolved the patient's diarrhea and eradicated C. difficile bacteriologically without any severe complications. Molecular biological analysis of the patient's fecal microbiota showed that FMT could dramatically change the altered composition of intestinal microbiota and restore its diversity. Despite the restoration of the intestinal microbiota, FMT could not prevent a relapse of UC in this patient. However, it improved the intestinal symptoms of CDI and could prevent further recurrences of CDI.
Clostridium difficile
;
Clostridium
;
Colitis, Ulcerative
;
Colonoscopy
;
Diarrhea
;
Dysbiosis
;
Fecal Microbiota Transplantation
;
Gastrointestinal Microbiome
;
Humans
;
Microbiota
;
Recurrence
;
Ulcer
7.The Present Situation Regarding Kampo Medicine Use and Kampo Education in Three Hokkaido Hospitals
Izumi SATO ; Keiko MAMIYA ; Yasuhito Kato ; Satoshi SHIMANO ; Koichi OTAKI ; Toshio AWAYA ; Yoshikazu TASAKI ; Takayuki KUNISAWA ; Hiroshi IWASAKI
Kampo Medicine 2017;68(2):157-164
Medical therapies, adapted to local requirements, are necessary in the field of community medicine. Generalized medical treatment is often all there is in Japan's Konsen Area, due to the large number of elderly people and a paucity of medical institutions. Kampo medical treatment is useful for elderly patients with plural diseases, and the demand for such treatment has been increasing. Therefore, we collected data on Kampo prescriptions prescribed by the doctors at the Nakashibetsu Municipal Hospital, which is the main local hospital in the Konsen Area, from 2010 to 2013. We conducted similar investigations at the Kushiro Red Cross Hospital in Kushiro city, which is centrally located in the Konsen Area, and at Asahikawa Medical University Hospital in Asahikawa, central Hokkaido. The aim of these investigations was to compare Kampo medicine use based on hospital location and size. The results can be used in community medicine to enhance the use of Kampo medicine with increase for its demand. Medical students and doctors should be educated in Kampo medicines, since their prescriptions have a significant impact on community health.
8.A Case of Primary Cutaneous Gamma-Delta T-Cell Lymphoma with Pautrier Microabscess.
Kohei KATO ; Takeshi NAMIKI ; Makiko UENO ; Madoka IIKAWA ; Shown TOKORO ; Aya NISHIZAWA ; Kouhei YAMAMOTO ; Keiko MIURA ; Hiroo YOKOZEKI
Annals of Dermatology 2017;29(2):229-232
No abstract available.
Lymphoma, T-Cell*
;
T-Lymphocytes*
9.High-Grade, Advanced Tongue Cancer Treated with Arterial Injection Chemoradiotherapy by Multidisciplinary Medical Teams
Akio YASUI ; Shoichiro KITAJIMA ; Hisanobu MARUO ; Harumi MIZUTANI ; Emi SAWAKI ; Mariko MIZOGUCHI ; Yuna KATO ; Shinichi ISHIKAWA ; Masayo SOBUE ; Akiko UNESOKO ; Keiko NAITO ; Masaki NAKATA ; Hayato SIGEMURA ; Mayu MATSUOKA ; Tomoko NODA ; Tetsuya ANDO ; Minoru TERASAWA
Journal of the Japanese Association of Rural Medicine 2016;65(1):83-92
In recent years, favorable therapeutic outcomes have been reported for arterial injection chemoradiotherapy for tongue cancer. The present case involves an 80-year-old woman in our palliative care department who had high-grade, advanced tongue cancer. Because there was a request for surgery to prevent airway occlusion due to growth of the tumor, she was referred to our department in April 2009. As a treatment policy for controlling tumor growth in high-grade, advanced tongue cancer, arterial injection chemoradiotherapy was carried out through the superficial temporal artery, with a tongue artery catheter in place on both sides. Therapeutic effect was obtained, and it was possible to avoid airway occlusion through tumor regression. Dysphagia and dysphemia were improved, which in turn improved quality of life. In this case, there was an opportunity to carry out multidisciplinary team medicine, including support from the oral care and palliative care teams as part of the process of cancer therapy. Here, we present our findings in this case.
10.Increased Infiltration of CD8⁺ T Cells by Dacarbazine in a Patient with Mucosal Penile Melanoma Refractory to Nivolumab.
Masato FUNAZUMI ; Takeshi NAMIKI ; Yumi ARIMA ; Kohei KATO ; Kohei NOJIMA ; Kentaro TANAKA ; Keiko MIURA ; Hiroo YOKOZEKI
Annals of Dermatology 2016;28(4):486-490
Primary penile melanomas are rare tumors that represent less than 0.1% of all melanomas. We report a case of a 60-year-old Japanese male with a mucosal penile melanoma and describe an increased CD8⁺ T cell infiltration in brain after dacarbazine (DTIC) administration. After partial penectomy and left inguinal lymphadenectomy, he developed multiple lung, bone, spleen, brain and skin metastases. He was treated with interferon-β, DTIC and nivolumab. However, the metastases were not reduced in size. Immunohistochemistry showed an increase of CD8⁺ T cell infiltration and programmed death-ligand 1 (PD-L1) expression after the administration of DTIC, but the expression of programmed cell death protein 1 (PD-1) was negative. We speculate that DTIC exerted immunostimulatory effects, but nivolumab was ineffective due to the negative expression of PD-1 and/or an insufficient infiltration of CD8⁺ T cells. Although this is only one case, this case report could be the first step to discuss the development of effective therapies against melanoma to take advantage of the increased CD8⁺ T cell infiltration elicited by chemotherapeutic agents. It would be beneficial to pay more attention to the relationship between DTIC and immune checkpoint modulators.
Asian Continental Ancestry Group
;
Brain
;
Cell Death
;
Dacarbazine*
;
Humans
;
Immunohistochemistry
;
Lung
;
Lymph Node Excision
;
Male
;
Melanoma*
;
Middle Aged
;
Neoplasm Metastasis
;
Skin
;
Spleen
;
T-Lymphocytes*


Result Analysis
Print
Save
E-mail